During the past decade, UMHAT Pulmed OOD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMHAT Pulmed OOD" #1 sponsor was "R-Pharm International, LLC" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT Pulmed OOD" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UMHAT Pulmed OOD" are "Rheumatoid Arthritis" (3 trials), "Ankylosing Spondylitis" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Multiple Sclerosis" (1 trials) and "Non-Radiographical Axial Spondyloarthritis" (1 trials). Many other conditions were trialed in "UMHAT Pulmed OOD" in a lesser frequency.

Most popular intervention types in "UMHAT Pulmed OOD" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Adalimumab 40mg q2w" (1 trials), "Concomitant treatment" (1 trials), "Filgotinib" (1 trials) and "IMU-838" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT Pulmed OOD" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UMHAT Pulmed OOD". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UMHAT Pulmed OOD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT Pulmed OOD, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".